Prescribing information



Beovu is indicated in adults for the treatment of neovascular (wet) AMD.1


AMD, age-related macular degeneration.


  1. Beovu Summary of Product Characteristics, 2020.
BEO20-C039j(1) December 2020

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]